Annual Net Income
-$143.10 M
+$22.19 M+13.43%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual net profit is -$143.10 million, with the most recent change of +$22.19 million (+13.43%) on December 31, 2023.
- During the last 3 years, KPTI annual net income has risen by +$53.17 million (+27.09%).
- KPTI annual net income is now -1287.83% below its all-time high of -$10.31 million, reached on December 31, 2011.
Performance
KPTI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$32.07 M
-$55.86 M-234.80%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly net profit is -$32.07 million, with the most recent change of -$55.86 million (-234.80%) on September 30, 2024.
- Over the past year, KPTI quarterly net income has dropped by -$55.86 million (-234.80%).
- KPTI quarterly net income is now -182.83% below its all-time high of $38.72 million, reached on December 31, 2021.
Performance
KPTI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$87.48 M
+$2.43 M+2.71%
September 30, 2024
Summary
- As of February 8, 2025, KPTI TTM net profit is -$87.48 million, with the most recent change of +$2.43 million (+2.71%) on September 30, 2024.
- Over the past year, KPTI TTM net income has increased by +$2.43 million (+2.71%).
- KPTI TTM net income is now -2306.57% below its all-time high of -$3.63 million, reached on September 30, 2012.
Performance
KPTI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
KPTI Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.4% | -234.8% | +2.7% |
| 3 y3 years | +27.1% | +38.1% | +57.6% |
| 5 y5 years | +19.8% | +22.5% | +56.2% |
KPTI Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.3% | +13.4% | -182.8% | +34.6% | at high | +47.1% |
| 5 y | 5-year | -15.3% | +28.3% | -182.8% | +44.1% | at high | +57.9% |
| alltime | all time | -1287.8% | +28.3% | -182.8% | +51.5% | -2306.6% | +59.5% |
Karyopharm Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$32.07 M(-234.8%) | -$87.48 M(-2.7%) |
| Jun 2024 | - | $23.79 M(-163.7%) | -$89.91 M(-38.6%) |
| Mar 2024 | - | -$37.36 M(-10.7%) | -$146.34 M(+2.3%) |
| Dec 2023 | -$143.10 M(-13.4%) | -$41.84 M(+21.2%) | -$143.10 M(+2.4%) |
| Sep 2023 | - | -$34.51 M(+5.7%) | -$139.77 M(-1.3%) |
| Jun 2023 | - | -$32.63 M(-4.4%) | -$141.59 M(-10.4%) |
| Mar 2023 | - | -$34.13 M(-11.4%) | -$158.02 M(-4.4%) |
| Dec 2022 | -$165.29 M(+33.2%) | -$38.51 M(+6.0%) | -$165.29 M(+87.7%) |
| Sep 2022 | - | -$36.32 M(-26.0%) | -$88.06 M(-15.0%) |
| Jun 2022 | - | -$49.06 M(+18.5%) | -$103.55 M(-4.2%) |
| Mar 2022 | - | -$41.40 M(-206.9%) | -$108.07 M(-12.9%) |
| Dec 2021 | -$124.09 M(-36.8%) | $38.72 M(-174.7%) | -$124.09 M(-39.8%) |
| Sep 2021 | - | -$51.81 M(-3.3%) | -$206.23 M(-0.8%) |
| Jun 2021 | - | -$53.58 M(-6.7%) | -$207.91 M(+3.6%) |
| Mar 2021 | - | -$57.41 M(+32.2%) | -$200.76 M(+2.3%) |
| Dec 2020 | -$196.27 M(-1.7%) | -$43.42 M(-18.8%) | -$196.27 M(-2.6%) |
| Sep 2020 | - | -$53.49 M(+15.2%) | -$201.50 M(+6.4%) |
| Jun 2020 | - | -$46.43 M(-12.3%) | -$189.37 M(+1.6%) |
| Mar 2020 | - | -$52.93 M(+8.8%) | -$186.36 M(-6.6%) |
| Dec 2019 | -$199.59 M(+11.9%) | -$48.65 M(+17.6%) | -$199.59 M(-4.6%) |
| Sep 2019 | - | -$41.37 M(-4.7%) | -$209.15 M(-3.1%) |
| Jun 2019 | - | -$43.41 M(-34.4%) | -$215.87 M(+4.7%) |
| Mar 2019 | - | -$66.16 M(+13.7%) | -$206.11 M(+15.5%) |
| Dec 2018 | -$178.41 M | -$58.21 M(+21.1%) | -$178.41 M(+12.0%) |
| Sep 2018 | - | -$48.08 M(+42.9%) | -$159.24 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$33.66 M(-12.5%) | -$141.79 M(+3.1%) |
| Mar 2018 | - | -$38.46 M(-1.5%) | -$137.53 M(+6.6%) |
| Dec 2017 | -$128.98 M(+17.7%) | -$39.04 M(+27.4%) | -$128.98 M(+10.4%) |
| Sep 2017 | - | -$30.64 M(+4.3%) | -$116.88 M(+4.7%) |
| Jun 2017 | - | -$29.39 M(-1.8%) | -$111.66 M(-0.7%) |
| Mar 2017 | - | -$29.92 M(+11.1%) | -$112.44 M(+2.6%) |
| Dec 2016 | -$109.58 M(-7.3%) | -$26.93 M(+5.9%) | -$109.58 M(-1.9%) |
| Sep 2016 | - | -$25.43 M(-15.7%) | -$111.69 M(-4.2%) |
| Jun 2016 | - | -$30.16 M(+11.5%) | -$116.64 M(-2.1%) |
| Mar 2016 | - | -$27.06 M(-6.8%) | -$119.17 M(+0.8%) |
| Dec 2015 | -$118.18 M(+56.0%) | -$29.05 M(-4.4%) | -$118.18 M(+2.7%) |
| Sep 2015 | - | -$30.37 M(-7.1%) | -$115.06 M(+10.2%) |
| Jun 2015 | - | -$32.70 M(+25.4%) | -$104.41 M(+18.5%) |
| Mar 2015 | - | -$26.07 M(+0.5%) | -$88.15 M(+16.3%) |
| Dec 2014 | -$75.78 M(+123.2%) | -$25.93 M(+31.5%) | -$75.78 M(+22.2%) |
| Sep 2014 | - | -$19.72 M(+20.0%) | -$61.99 M(+20.2%) |
| Jun 2014 | - | -$16.43 M(+20.0%) | -$51.59 M(+22.8%) |
| Mar 2014 | - | -$13.69 M(+12.7%) | -$42.03 M(+23.8%) |
| Dec 2013 | -$33.95 M(+113.7%) | -$12.15 M(+30.3%) | -$33.95 M(+30.4%) |
| Sep 2013 | - | -$9.32 M(+35.7%) | -$26.04 M(+27.9%) |
| Jun 2013 | - | -$6.87 M(+22.4%) | -$20.35 M(+50.9%) |
| Mar 2013 | - | -$5.61 M(+32.4%) | -$13.48 M(+71.3%) |
| Dec 2012 | -$15.89 M(+54.1%) | -$4.24 M(+16.6%) | -$7.87 M(+116.6%) |
| Sep 2012 | - | -$3.63 M | -$3.63 M |
| Dec 2011 | -$10.31 M | - | - |
FAQ
- What is Karyopharm Therapeutics annual net profit?
- What is the all time high annual net income for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual net income year-on-year change?
- What is Karyopharm Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly net income year-on-year change?
- What is Karyopharm Therapeutics TTM net profit?
- What is the all time high TTM net income for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics TTM net income year-on-year change?
What is Karyopharm Therapeutics annual net profit?
The current annual net income of KPTI is -$143.10 M
What is the all time high annual net income for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual net profit is -$10.31 M
What is Karyopharm Therapeutics annual net income year-on-year change?
Over the past year, KPTI annual net profit has changed by +$22.19 M (+13.43%)
What is Karyopharm Therapeutics quarterly net profit?
The current quarterly net income of KPTI is -$32.07 M
What is the all time high quarterly net income for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly net profit is $38.72 M
What is Karyopharm Therapeutics quarterly net income year-on-year change?
Over the past year, KPTI quarterly net profit has changed by -$55.86 M (-234.80%)
What is Karyopharm Therapeutics TTM net profit?
The current TTM net income of KPTI is -$87.48 M
What is the all time high TTM net income for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high TTM net profit is -$3.63 M
What is Karyopharm Therapeutics TTM net income year-on-year change?
Over the past year, KPTI TTM net profit has changed by +$2.43 M (+2.71%)